129 related articles for article (PubMed ID: 2117285)
1. Cyclic interferon gamma application in patients with renal cell carcinoma.
Grups JW; Frohmüller HG
Prog Clin Biol Res; 1990; 350():257-62. PubMed ID: 2117285
[No Abstract] [Full Text] [Related]
2. Anti-tumor effects of interleukin 2 against renal cell carcinoma. In vitro study and clinical application.
Marumo K; Tazaki H
Prog Clin Biol Res; 1990; 350():263-73. PubMed ID: 2117286
[No Abstract] [Full Text] [Related]
3. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
[TBL] [Abstract][Full Text] [Related]
4. New prospects in the management of metastatic renal cell carcinoma. Experimental and clinical data.
Debruyne FM; Franssen MP; Beniers AJ; Schalken JA; de Mulder PH
Prog Clin Biol Res; 1990; 350():243-55. PubMed ID: 2117284
[No Abstract] [Full Text] [Related]
5. Interferons in renal-cell carcinoma: status and prospects.
De Mulder PH; Debruyne FM; Beniers AJ
Prog Clin Biol Res; 1990; 348():49-59. PubMed ID: 1696737
[No Abstract] [Full Text] [Related]
6. Recombinant alpha-interferon plus vinblastine in metastatic renal-cell cancer: analysis of response and survival in 58 evaluable patients.
Bergerat JP; Ford J; Herbrecht R; Dufour P; Oberling F; Jacqmin D; Bollack C; Prevot G; Salze P; Jurascheck F
Prog Clin Biol Res; 1990; 348():137-50. PubMed ID: 2385604
[No Abstract] [Full Text] [Related]
7. Recombinant alpha-2 or gamma interferon in the treatment of metastatic renal cell carcinoma: results of two phase II/III trials.
Otto U; Schneider AW; Conrad S; Klosterhalfen H
Prog Clin Biol Res; 1990; 350():275-82. PubMed ID: 2117287
[No Abstract] [Full Text] [Related]
8. Cancer immunotherapy using tumor-infiltrating lymphocytes.
Figlin RA
Semin Hematol; 1992 Apr; 29(2 Suppl 1):33-5. PubMed ID: 1535456
[No Abstract] [Full Text] [Related]
9. [Immunological study of the postoperative adjuvant treatment with interferon gamma in patients with renal cell cancer--measurement of peripheral blood lymphocyte subsets with three color flow cytometry].
Yasunaga Y; Nishimura K; Miura H; Takatera H; Kuroda H; Kishimoto T; Fujioka H
Hinyokika Kiyo; 1995 Feb; 41(2):85-92. PubMed ID: 7702012
[TBL] [Abstract][Full Text] [Related]
10. Interferon-alpha and interleukin-2 in the treatment of renal cell cancer.
Holdener EE; Emmons RP; Brunda M; Evans L; Levitt D
Prog Clin Biol Res; 1990; 348():61-9. PubMed ID: 2201034
[No Abstract] [Full Text] [Related]
11. [Long-term immunological study on postoperative adjuvant treatment with interferon-gamma in patients with renal cell carcinoma who underwent nephrectomy].
Miura H; Arai H; Matsuoka A; Yazawa K; Satoh E; Nishimura K; Honda M; Fujioka H
Hinyokika Kiyo; 1999 Feb; 45(2):79-83. PubMed ID: 10212778
[TBL] [Abstract][Full Text] [Related]
12. [Immunological effect of recombinant interferon-gamma in renal cell carcinoma].
Kawata N; Ono M; Endo M; Ichinose T; Hamada T; Hirano D; Fuse T; Takimoto Y
Hinyokika Kiyo; 1993 Jun; 39(6):511-5. PubMed ID: 8337976
[TBL] [Abstract][Full Text] [Related]
13. [Results of low dosage cyclic interferon-gamma therapy of metastatic renal cell carcinoma].
Hofmockel G; Wirth MP; Heimbach D; Frohmüller HG
Urologe A; 1993 Jul; 32(4):290-4. PubMed ID: 8372410
[TBL] [Abstract][Full Text] [Related]
14. Recombinant interferon gamma in the treatment of metastatic renal cell carcinoma. Results of a phase II trial.
Otto U; Conrad S; Schneider AW; Klosterhalfen H
Arzneimittelforschung; 1988 Nov; 38(11):1658-60. PubMed ID: 3145743
[TBL] [Abstract][Full Text] [Related]
15. The antitumor effects of IFN- beta against human renal cell carcinoma in athymic nude mice.
Shirahama T; Kayajima T; Ohi Y
In Vivo; 1989; 3(5):345-9. PubMed ID: 2519876
[TBL] [Abstract][Full Text] [Related]
16. In vivo activation of LAK cells during systemic IL-2 therapy.
Lang P; Vitté-Mony I; Farace F; Stancou R; Triebel F; Escudier B; Hercend T; Bertoglio J
Eur Cytokine Netw; 1990; 1(3):185-8. PubMed ID: 2129800
[No Abstract] [Full Text] [Related]
17. [A study of effective administration of recombinant interferon-gamma in renal cell carcinoma regarding immunological influence on peripheral blood lymphocytes].
Kawata N; Ono M; Kodama M; Yamanaka Y; Hirakata H; Hirano D; Fuse T; Takimoto Y
Hinyokika Kiyo; 1995 Jan; 41(1):21-6. PubMed ID: 7900565
[TBL] [Abstract][Full Text] [Related]
18. [Individualized therapy with alpha-interferon in metastatic renal cell carcinoma].
Gross AJ; Dieckmann KP; Krain J; Huland H
Urologe A; 1995 Mar; 34(2):158-61. PubMed ID: 7754588
[TBL] [Abstract][Full Text] [Related]
19. [Clinical trial of inhalant recombinant interferon-gamma in patients with pulmonary metastasis from renal tumor (preliminary report)].
Kawata N; Takimoto Y; Hirakata H; Fuse T; Hirano D; Yamanaka Y
Hinyokika Kiyo; 1994 Sep; 40(9):773-6. PubMed ID: 7801837
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and pharmacokinetics of continuous subcutaneous infusion of low-dose interferon-gamma: a pilot study.
Satake I; Tari K; Nakagomi K; Ozawa K
Jpn J Clin Oncol; 1993 Dec; 23(6):356-62. PubMed ID: 8283789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
